Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,900 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2022) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 6MB, 247 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 2949 results:
Author Title Type [ Year(Asc)]
2020
J. E. Amegadzie, Gamble, J. M., Farrell, J., and Gao, Z., “Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study”, Int J Chron Obstruct Pulmon Dis, vol. 15, pp. 2355-2366, 2020.
A. Tucker, Wang, Z., Rotalinti, Y., and Myles, P., “Generating high-fidelity synthetic patient data for assessing machine learning healthcare software”, NPJ Digit Med, 2020.
J. Wu, Mackie, S. L., and Pujades-Rodriguez, M., “Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis”, BMJ Open Diabetes Res Care, vol. 8, 2020.
R. E. Costello, Yimer, B. B., Roads, P., Jani, M., and Dixon, W. G., “Glucocorticoid use is associated with an increased risk of hypertension”, Rheumatology (Oxford), 2020.
X. V. Peng, McCrimmon, R. J., Shepherd, L., Boss, A., Lubwama, R., Dex, T., Skolnik, N., Ji, L., Avogaro, A., and Blonde, L., “Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study”, Diabetes Ther, 2020.
S. Jarvis, Parslow, R. C., Hewitt, C., Mitchell, S., and Fraser, L. K., “GPs' role in caring for children and young people with life-limiting conditions: a retrospective cohort study”, Br J Gen Pract, 2020.
L. K. Fraser, Murtagh, F. E. M., Sheldon, T., Gilbody, S., and Hewitt, C., “Health of mothers of children with a life-limiting condition: a protocol for comparative cohort study using the Clinical Practice Research Datalink”, BMJ Open, vol. 10, p. e034024, 2020.
A. Gayle, Schoof, N., Alves, M., Clarke, D., Raabe, C., Das, P., Del Galdo, F., and Maher, T. M., “Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis”, Adv Ther, 2020.
D. Lewer, Padmanathan, P., M. Arfeen, Q. Ul, Denaxas, S., Forbes, H., Gonzalez-Izquierdo, A., and Hickman, M., “Healthcare use by people who use illicit opioids (HUPIO): development of a cohort based on electronic primary care records in England”, Wellcome Open Res, vol. 5, p. 282, 2020.
C. L. Morgan, Varga, S., Tsong, W., Jenkins-Jones, S., and Holden, S., “Healthcare utilization and associated costs following initiation of perampanel in patients with epilepsy”, Epilepsy Behav, vol. 110, p. 107137, 2020.
S. Hawley, Shaw, N. J., Delmestri, A., Prieto-Alhambra, D., Cooper, C., Pinedo-Villanueva, R., and Javaid, M. K., “Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRD”, Rheumatology (Oxford), 2020.
R. Ma, Cecil, E., Bottle, A., French, R., and Saxena, S., “Impact of a pay-for-performance scheme for long-acting reversible contraceptive (LARC) advice on contraceptive uptake and abortion in British primary care: An interrupted time series study”, PLoS Med, vol. 17, p. e1003333, 2020.
S. L. Lay-Flurrie, Sheppard, J. P., Stevens, R. J., Mallen, C., Heneghan, C., Hobbs, F. D. R., Williams, B., Mant, J., and McManus, R. J., “Impact of Changes to National Hypertension Guidelines on Hypertension Management and Outcomes in the United Kingdom”, Hypertension, vol. 75, pp. 356-364, 2020.
C. S. Cabrera, Lee, A. S., Olsson, M., Schnecke, V., Westman, K., Lind, M., Greasley, P. J., and Skrtic, S., “Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes”, Kidney Int Rep, vol. 5, pp. 1651-1660, 2020.
A. Pate, Emsley, R., and Van Staa, T., “Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care”, Br J Gen Pract, vol. 70, pp. e765-e771, 2020.
A. Pate, Emsley, R., Sperrin, M., Martin, G. P., and Van Staa, T., “Impact of sample size on the stability of risk scores from clinical prediction models: a case study in cardiovascular disease”, Diagn Progn Res, vol. 4, p. 14, 2020.
A. Pate, Elliott, R. A., Gkountouras, G., Thompson, A., Emsley, R., and Van Staa, T., “The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented”, Pharmacoepidemiol Drug Saf, 2020.
J. Tazare, Smeeth, L., Evans, S. J. W., Williamson, E., and Douglas, I. J., “Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records”, Pharmacoepidemiol Drug Saf, 2020.
H. J. Forbes, Bhaskaran, K., Grint, D., Hu, V. H., Langan, S. M., McDonald, H. I., Morton, C., Smeeth, L., Walker, J. L., and Warren-Gash, C., “Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data”, Br J Dermatol, 2020.
F. Tyrer, Zaccardi, F., Khunti, K., and Morriss, R., “Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care”, Obesity (Silver Spring), vol. 28, pp. 977-984, 2020.
J. M. Ryan, Cameron, M. H., Liverani, S., Smith, K. J., O'Connell, N., Peterson, M. D., Anokye, N., Victor, C., and Boland, F., “Incidence of falls among adults with cerebral palsy: a cohort study using primary care data”, Dev Med Child Neurol, vol. 62, pp. 477-482, 2020.
C. V. Chalitsios, McKeever, T. M., and Shaw, D. E., “Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study”, Eur Respir J, 2020.
L. Grønbaek, Otete, H., Ban, L., Crooks, C., Card, T., Jepsen, P., and West, J., “Incidence, prevalence, and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study”, Liver Int, 2020.
M. S. M. Persson, Harman, K. E., Vinogradova, Y., Langan, S. M., Hippisley-Cox, J., Thomas, K. S., and Gran, S., “Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study”, Br J Dermatol, 2020.
O. B. Esan, Perera, R., McCarthy, N., Violato, M., and Fanshawe, T. R., “Incidence, risk factors, and health service burden of sequelae of campylobacter and non-typhoidal salmonella infections in England, 2000-2015: A retrospective cohort study using linked electronic health records”, J Infect, 2020.
R. Persson, Lee, S., Yood, M. U., Wagner, M., Minton, N., Niemcryk, S., Lindholm, A., Evans, A., and Jick, S., “Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study”, Mult Scler Relat Disord, vol. 37, p. 101423, 2020.
R. Persson, Lee, S., Yood, M. U., Mc, M. R. Wagner, Minton, N., Niemcryk, S., Lindholm, A., Evans, A. M., and Jick, S., “Incident depression in patients diagnosed with multiple sclerosis: a multi-database study”, Eur J Neurol, 2020.
C. Zecca, Disanto, G., Sacco, R., MacLachlan, S., Kuhle, J., Ramagopalan, S. V., and Gobbi, C., “Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study”, J Neurol, 2020.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., “Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes”, Diabet Med, 2020.
T. Rathod-Mistry, Marshall, M., Campbell, P., Bailey, J., Chew-Graham, C. A., Croft, P., Frisher, M., Hayward, R., Negi, R., Robinson, L., Singh, S., Sumathipala, A., Thein, N., Walters, K., Weich, S., and Jordan, K. P., “Indicators of dementia disease progression in primary care: an electronic health record cohort study”, Eur J Neurol, 2020.
R. Persson, Lee, S., M. Yood, U., Mc, C. M. Wagner, Minton, N., Niemcryk, S., Lindholm, A., Evans, A. M., and Jick, S. S., “Infections in patients diagnosed with multiple sclerosis: A multi-database study”, Mult Scler Relat Disord, vol. 41, p. 101982, 2020.
J. P. A. Houwen, Egberts, A. C. G., de Boer, A., van Maarseveen, E. M., Houwen, R. H. J., and Lalmohamed, A., “Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study”, Br J Clin Pharmacol, 2020.
C. S. Osam, Pierce, M., Hope, H., Ashcroft, D. M., and Abel, K. M., “The influence of maternal mental illness on vaccination uptake in children: a UK population-based cohort study”, Eur J Epidemiol, 2020.
L. E. Clarson, Bajpai, R., Whittle, R., Belcher, J., A. Sultan, A., Kwok, C. S., Welsh, V., Mamas, M., and Mallen, C. D., “Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction”, Heart, 2020.
C. Martinez, Wallenhorst, C., Rietbrock, S., and Freedman, B., “Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
H. J. L. Heerspink, Karasik, A., Thuresson, M., Melzer-Cohen, C., Chodick, G., Khunti, K., Wilding, J. P. H., Rodriguez, L. A. Garcia, Cea-Soriano, L., Kohsaka, S., Nicolucci, A., Lucisano, G., Lin, F. J., Wang, C. Y., Wittbrodt, E., Fenici, P., and Kosiborod, M., “Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study”, Lancet Diabetes Endocrinol, vol. 8, pp. 27-35, 2020.
M. J. Brookes, Waller, J., Cappelleri, J. C., Modesto, I., DiBonaventura, M. D., Bohm, N., Mokgokong, R., Massey, O., Wood, R., and Bargo, D., “Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis”, BMJ Open Gastroenterol, vol. 7, 2020.
I. Schlackow, Simons, C., Oke, J., Feakins, B., O'Callaghan, C. A., Hobbs, F. D. R., Lasserson, D., Stevens, R. J., Perera, R., and Mihaylova, B., “Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data”, PLoS Med, vol. 17, p. e1003478, 2020.
C. Salisbury, Lay-Flurrie, S., Bankhead, C. R., Fuller, A., Murphy, M., Caddick, B., Ordonez-Mena, J. M., Holt, T., Nicholson, B. D., Perera, R., and Hobbs, F. R., “Measuring the complexity of general practice consultations: a Delphi and cross-sectional study in English primary care”, Br J Gen Pract, 2020.
S. Price, Zhang, X., and Spencer, A., “Measuring the impact of national guidelines: What methods can be used to uncover time-varying effects for healthcare evaluations?”, Soc Sci Med, vol. 258, p. 113021, 2020.
Y. Tang, Weiss, T., Liu, J., Rajpathak, S., and Khunti, K., “Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study”, J Clin Transl Endocrinol, vol. 20, p. 100225, 2020.
A. T. O. Nickinson, Coles, B., Zaccardi, F., Gray, L. J., Payne, T., Bown, M. J., Davies, R. S. M., Khunti, K., and Sayers, R. D., “Missed Opportunities for Timely Recognition of Chronic Limb-Threatening Ischaemia in Patients Undergoing a Major Amputation: A Population Based Cohort Study Using the UK's Clinical Practice Research Datalink”, Eur J Vasc Endovasc Surg, 2020.
R. Partington, Muller, S., Mallen, C. D., A. Sultan, A., and Helliwell, T., “Mortality among patients with polymyalgia rheumatica: A retrospective cohort study”, Arthritis Care Res (Hoboken), 2020.
I. E. M. Bultink, de Vries, F., van Vollenhoven, R. F., and Lalmohamed, A., “Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls”, Rheumatology (Oxford), 2020.
M. Stafford, Deeny, S., Dreyer, K., and Jenny, S., “Multimorbidity within households and use of health and social care”, BJGP Open, 2020.
C. J. Taylor, Ordonez-Mena, J. M., Jones, N. R., Roalfe, A. K., Lay-Flurrie, S., Marshall, T., and Hobbs, F. D. R., “National trends in heart failure mortality in men and women, United Kingdom, 2000-2017”, Eur J Heart Fail, 2020.
C. J. van den Dries, van Doorn, S., Souverein, P., Pajouheshnia, R., Moons, K. G. M., Hoes, A. W., Geersing, G. J., and van den Ham, H. A., “The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation”, TH Open, vol. 4, pp. e417-e426, 2020.
C. W. le Roux, Hartvig, N. V., Haase, C. L., Nordsborg, R. B., Olsen, A. H., and Satylganova, A., “Obesity, cardiovascular risk and healthcare resource utilization in the UK”, Eur J Prev Cardiol, p. 2047487320925639, 2020.
M. Katsoulis, Pasea, L., Lai, A. G., Dobson, R. J. B., Denaxas, S., Hemingway, H., and Banerjee, A., “Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of lockdown? A population-based electronic health record study”, Public Health, vol. 191, pp. 41-47, 2020.
G. Glover, Williams, R., and Oyinlola, J., “An observational cohort study of numbers and causes of preventable general hospital admissions in people with and without intellectual disabilities in England”, J Intellect Disabil Res, 2020.
[Page last reviewed 4 January 2022]